F13A1 anticorps (AA 46-181)
-
- Antigène Voir toutes F13A1 Anticorps
- F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
-
Épitope
- AA 46-181
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp F13A1 est non-conjugé
-
Application
- ELISA, Western Blotting (WB), Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Purification
- Purified
- Pureté
- Protein G affinity chromatography
- Immunogène
- A human partial recombinant protein corresponding to amino acids 46-181 was used as the immunogen for the Factor XIIIa antibody.
- Clone
- F13A1-1448
- Isotype
- IgG2b kappa
- Top Product
- Discover our top product F13A1 Anticorps primaire
-
-
- Indications d'application
-
Titering of the Factor XIIIa antibody may be required for optimal performance.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.\. ELISA: 2-4 μg/mL, order the BSA-free formulation for coating,Immunofluorescence: 1-2 μg/mL,Flow Cytometry: 0.5-1 μg/million cells in 0.1ml,Western blot: 0.5-1 μg/mL,Immunohistochemistry (FFPE): 1-2 μg/mL for 30 min at RT,Prediluted IHC only format: incubate for 30 min at RT (1)
- Restrictions
- For Research Use only
-
- Concentration
- 0.2 mg/mL
- Buffer
- 0.2 mg/mL in 1X PBS with 0.1 mg/mL BSA (US sourced) and 0.05 % sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- 4 °C,-20 °C
- Stockage commentaire
- Store the Factor XIIIa antibody at 2-8°C (with azide) or aliquot and store at -20°C or colder (without azide).
-
- Antigène
- F13A1 (Coagulation Factor XIII, A1 Polypeptide (F13A1))
- Autre désignation
- Factor XIIIa / F13A1 (F13A1 Produits)
- Synonymes
- anticorps F13a, anticorps f13a1, anticorps wu:fo83d04, anticorps zgc:153334, anticorps F13A1, anticorps F13A, anticorps 1200014I03Rik, anticorps AI462306, anticorps coagulation factor XIII A1 chain, anticorps coagulation factor XIII, A1 polypeptide b, anticorps coagulation factor XIII A chain, anticorps coagulation factor XIII, A1 subunit, anticorps F13a1, anticorps f13a1b, anticorps F13A1
- Sujet
- Factor XIIIa has been identified in platelets, megakaryocytes, and fibroblast-like mesenchymal or histiocytic cells in the placenta, uterus, and prostate, monocytes and macrophages and dermal dendritic cells. Anti-Factor XIIIa has been found to be useful in differentiating between dermatofibroma (almost all cases are positive), dermatofibrosarcoma protuberans (-/+) and desmoplastic malignant melanoma (-). Anti-Factor XIIIa positivity is also seen in capillary hemagioblastoma, hemangioendothelioma, hemangiopericytoma, xanthogranuloma, xanthoma, hepatocellular carcinoma, glomus tumor, and meningioma.
-